A groundbreaking Phase 1 clinical trial showed that vagus nerve stimulation (VNS) combined with prolonged exposure therapy completely eliminated PTSD diagnoses in all nine participants for up to six months. This innovative approach, utilizing a miniaturized implanted device, enhances neuroplasticity, addressing the limitations of traditional therapies for treatment-resistant PTSD. A larger, double-blind Phase 2 trial is underway to confirm these promising results and seek FDA approval, offering potential relief for millions suffering from this debilitating disorder.

Prepared by Olivia Bennett and reviewed by editorial team.